Organization: Central University of Punjab
Location: Bathinda, Punjab, India
Project Title: Design, Synthesis and Biological Assessment of Novel Anti-Lung Cancer Epidermal Growth Factor Receptor-Proteolysis Targeting Chimeras (EGFR-PROTACs)
File Number: CRG/2023/000749
Principal Investigator: Professor Raj Kumar, Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Village Ghudda, Bathinda, Punjab-151401
Co-Investigators:
- Prof. Kulbhushan Tikoo, Department of Pharmacology and Toxicology, NIPER, Mohali
- Dr. Uma Shankar, Department of Pharmacology, Central University of Punjab, Bathinda
Project Duration: 36 months
Number of Posts: 01
Age: As per Anusandhan National Research Foundation, SERB Rules
Fellowship: Rs 37,000/- per month + HRA as per the SERB, DST guidelines
Tenure: 3 Years (Approx.)
Essential Qualifications:
- First Class in M.Pharm / M.S (Pharm.) / M. Tech / M.Sc. in Pharmaceutical Sciences / Organic Chemistry (Preferable specialization in Pharmaceutical Chemistry / Natural Products Chemistry / Medicinal Chemistry or equivalent).
Desirable Qualifications:
- Experience in organic synthesis or semi synthesis of medicinally active compounds, their isolation, purification, and characterization through spectroscopic techniques.
- Fundamental knowledge of biological anticancer assays.
Terms and Conditions:
- Interested candidates are requested to send their application with the prescribed format available on the university website here to the project investigator by email: raj.khunger@cup.edu.in.
- For more details/clarification, please get in touch with Project Investigator: Prof. Raj Kumar on E-mail: raj.khunger@cup.edu.in.
- No TA/DA will be paid for attending the interview.
- Candidates appearing online for the interview must submit the signed and scanned PDF of the application form and self-attested copies of all the supporting documents through email at raj.khunger@cup.edu.in.
Last Date to Apply: 09.07.2024, 5.00 PM
Date of Interview: 11.07.2024, 11:00 AM onwards (online/offline Interview-hybrid mode)
